Role of fibronectin and complement in immunopathogenesis of acute and subacute hepatic failure

M Irshad1, S K Acharya, Y K Joshi

  • 1Department of Laboratory Medicine, All India Institute of Medical Sciences, New Delhi.

Insights

Plasma fibronectin (FN) and C3d levels are altered in acute liver failure patients. Reduced FN and elevated C3d indicate immune system involvement in viral hepatitis pathogenesis.

Area of Science:

  • Hepatology
  • Immunology
  • Virology

Background:

  • Viral hepatitis can lead to acute liver failure (ALF), a severe condition with high mortality.
  • The immunopathogenesis of ALF involves complex interactions between the host immune system and viral agents.
  • Understanding biomarkers associated with ALF progression is crucial for diagnosis and treatment.

Purpose of the Study:

  • To investigate plasma levels of soluble fibronectin (FN), C3d, and Ba in patients with acute viral hepatitis (AVH), fulminant hepatic failure (FHF), and subacute hepatic failure (SAHF).
  • To explore the potential roles of FN and complement system components in the immunopathogenesis of viral ALF.

Main Methods:

  • Plasma samples were collected from patients with AVH, FHF, SAHF, and healthy controls.
  • Levels of soluble fibronectin (FN), C3d (complement C3 breakdown product), and Ba (properdin factor B breakdown product) were measured.
  • Aetiological analysis identified hepatitis B, C, and non-A, non-B, non-C viruses as causative agents.

Main Results:

  • Plasma FN levels were significantly reduced in FHF and SAHF patients compared to AVH patients and healthy individuals.
  • Plasma C3d levels were significantly elevated in FHF and SAHF patients, irrespective of viral aetiology.
  • Ba levels remained comparable to normal values across all patient groups (AVH, FHF, SAHF).
  • FN levels were not dependent on the specific aetiological virus.

Conclusions:

  • Reduced fibronectin and elevated C3d may serve as indicators of severe liver injury in viral hepatitis.
  • These findings suggest a role for fibronectin and complement activation in the immunopathogenesis of viral acute liver failure.
  • Further research is warranted to elucidate the precise mechanisms involved.

Related Concept Videos

Fibronectins Connect Cells with ECM01:25

Fibronectins Connect Cells with ECM

Fibronectin is an adhesive glycoprotein present in the extracellular matrix of embryogenic and adult tissue. These molecules primarily aid in regulating cell motility and attachment. A fibronectin molecule is composed of two identical polypeptide chains attached to each other by a pair of disulfide bonds at the C-terminal.
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...